• Candelay Industries

FDA Updates Congress On CBD Product Labelling Accuracy

Originally posted to Marijuana Moment by Kyle Jaeger

The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years.

The report, which is responsive to a mandate attached to congressional appropriations legislation last year, shows significant inconsistencies between cannabinoids concentrations that are listed on labels and what the products actually contain. At the same time, it found negligible evidence that dangerous metals and minerals are added to these products.

Click here to read the full article.

0 views0 comments